An Exploratory Study of Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants Rivaroxaban in Patients With Left Ventricular Thrombus
Condition: Ventricular Mural Thrombus; Non-vitamin K Antagonist; Oral Anticoagulants Intervention: Drug: Rivaroxaban Sponsor: China National Center for Cardiovascular Diseases Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2021 Category: Research Source Type: clinical trials
An Exploratory Study of Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants Rivaroxaban in Patients With Left Ventricular Thrombus
Condition: Ventricular Mural Thrombosis Intervention: Drug: Rivaroxaban Sponsor: China National Center for Cardiovascular Diseases Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2021 Category: Research Source Type: clinical trials
An Exploratory Study of Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants Rivaroxaban in Patients With Left Ventricular Thrombus
Condition: Ventricular Mural Thrombus; Non-vitamin K Antagonist; Oral Anticoagulants Intervention: Drug: Rivaroxaban Sponsor: China National Center for Cardiovascular Diseases Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2021 Category: Research Source Type: clinical trials
Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty
Conditions: Atrial Fibrillation; Frailty; Anticoagulant-induced Bleeding; Stroke Interventions: Drug: Warfarin; Drug: Dabigatran; Drug: Rivaroxaban; Drug: Apixaban; Drug: Edoxaban Sponsor: Brigham and Women's Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 7, 2021 Category: Research Source Type: clinical trials
